Get the Stockscreener App
61.31
4.48%
-2.9811
Tempus Ai Inc stock is traded at $61.31, with a volume of 4.73M.
It is down -4.48% in the last 24 hours and up +17.98% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$64.29
Open:
$63.42
24h Volume:
4.73M
Relative Volume:
0.75
Market Cap:
$11.14B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-35.68
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-0.86%
1M Performance:
+17.98%
6M Performance:
+17.37%
1Y Performance:
-24.20%
1-Day Range:
$61.06
$64.91
1-Week Range:
$61.19
$66.30
52-Week Range:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
61.38 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
262.12 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.84 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
66.82 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
92.92 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Top Artificial Intelligence Stocks To Follow NowSeptember 9th - MarketBeat
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral - Investing.com
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com UK
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Best Artificial Intelligence Stocks To ConsiderSeptember 7th - MarketBeat
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility With A 21.6% Revenue Growth - DirectorsTalk Interviews
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - Quiver Quantitative
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Artificial Intelligence Stocks Worth WatchingSeptember 3rd - MarketBeat
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - finance.yahoo.com
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald initiates Tempus AI stock with overweight rating - Investing.com
Cantor Fitzgerald Initiates Tempus AI at Overweight With $80 Price Target - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
Cathie Wood's Investment Moves on September 1! Significantly Increased Stake in Rocket Lab, Reduced Holdings in Tempus AI - Moomoo
Tempus AI Inc (Derivatives) to Euro Price Today | Live TEM to EUR Converter & Exchange Rate - CryptoRank
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares - Benzinga
Tempus AI Director Nadja West Sells 3,000 Class A Shares Under Rule 10b5-1 Plan - Kalkine Media
Nadja West Sells 3,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI (TEM) director sells 3K shares, still holds 31,981 - Stock Titan
Tempus AI Inc (Derivatives) to Japanese Yen Price Today | Live TEM to JPY Converter & Exchange Rate - CryptoRank
Tempus AI (NASDAQ:TEM) Shares Gap UpShould You Buy? - MarketBeat
Tempus AI stock upgraded at Piper Sandler (TEM:NASDAQ) - Seeking Alpha
Tempus AI shares rise 2.7% following analyst actions - finance.yahoo.com
Tempus AI Inc (Derivatives) to United States Dollar Price Today | Live TEM to USD Converter & Exchange Rate - CryptoRank
Tempus AI stock rises on Piper Sandler upgrade to Overweight By Investing.com - Investing.com Nigeria
Tempus AI stock rises on Piper Sandler upgrade to Overweight - Investing.com
Tempus AI Inc (Derivatives) to Russian Ruble Price Today | Live TEM to RUB Converter & Exchange Rate - CryptoRank
Tempus AI Inc (Derivatives) to Chinese Yuan Price Today | Live TEM to CNY Converter & Exchange Rate - CryptoRank
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):